Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.Therefore, it is only effective in cancers with mutated and overactive EGFR.
Tags: Gefitinib Tablets manufacturer ,Gefitinib Tablets exporter, Gefitinib Tablets supplier, Gefitinib Tablets,Gefitinib potassium, whogmp approved Gefitinib potassium tablets manufacturer and supplier, Gefitinib Tablets distributor, Gefitinib Tablets drop shipper, Gefitinib Tablets 250 mg, Gefitinib Tablets 250 mg supplier, Gefitinib Tablets 250 mg.
ISO/GMP/c-GMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India
Registration: SaintroyLifescience is interested in registration of own brand or customer brands inministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free salecertificate and other required documents.
Export Country : SaintroyLifescience export Gefitinib Tablets to USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.